5.3.3: Viral hepatitis

Part of chapter 5 Infections, section 5.3 Antiviral drugs

High-level prescribing trends for Viral hepatitis (BNF section 5.3.3) across Horizon Healthcare for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Adefovir dipivoxil (0503031A0)
Adefovir Dipivoxil (0503030B0)
Boceprevir (0503032A0)
Boceprevir (0503030E0)
Daclatasvir (0503032E0)
Dasabuvir (0503032H0)
Elbasvir/grazoprevir (0503032I0)
Entecavir (0503031B0)
Entecavir (0503030C0)
Glecaprevir/pibrentasvir (0503032K0)
Ledipasvir/sofosbuvir (0503032F0)
Paritaprevir/ritonavir/ombitasvir (0503032G0)
Simeprevir (0503032D0)
Sofosbuvir (0503032C0)
Sofosbuvir/velpatasvir (0503032J0)
Sofosbuvir/velpatasvir/voxilaprevir (0503032L0)
Telaprevir (0503032B0)
Telaprevir (0503030F0)
Telbivudine (0503031C0)
Telbivudine (0503030D0)
Tenofovir alafenamide (0503031D0)
Feedback